However, frequent marijuana use causes inadequate activation of CB1, which can cause inflammation and atherosclerosis, and is associated with obesity, cancer and diabetes.
Cannabishas long been credited with anti-inflammatory properties. However, researchers at ETH Zurich have discovered that it is not only known psychoactive substances that are responsible for this, but that a compound that we ingest every day in plant nutrients also plays an important role. Cannabis compounds, in some cases through the endocannabinoid system, have been shown to affect some of the pillars of chronic inflammation.
However, in light of the large number of active molecules produced by cannabis and their interactions, sometimes synergistic, it is necessary to better specify treatments based on cannabis and active compounds, while using the synergy identified between phytomolecules in cannabis. Therefore, even if CBD or THC are considered to be potentially leading molecules, additional cannabis-derived compounds can be selected to improve their activity. There is both anecdotal and clinical evidence demonstrating the efficacy of cannabinoids in the treatment of MS. In addition, cannabinoids can affect immune responses and host resistance by disrupting the balance between cytokines produced by the T-helper, Th1 and Th2 subgroups.
Preparation of CASe from A cannabis strain with 5— 10% THC and 5— 11% CBD also produced significant levels of Δ9-THC only when CASe was prepared in a medium containing 30% MeOH. A study involving patients with Crohn's disease indicates that 10 out of 11 subjects experienced some form of relief thanks to cannabis, while avoiding steroids or other types of medications, which could lead to dangerous or addictive side effects. It should also be further considered whether endocannabinoids and cannabinoid receptors play a critical role during the normal inflammatory response. The endocannabinoid system (ECS) is a modulator of immune system activity, and the deregulation of this system is implicated in several chronic inflammations.
Exogenous cannabinoids have been shown to suppress T-cell-mediated immune responses by primarily inducing apoptosis and suppressing inflammatory cytokines and chemokines. However, the presence of biologically active cannabinoids in this CASe preparation further highlights its usefulness in evaluating the physiological and pathological implications of cannabis smoke. In another clinical trial, daily cannabis treatment was associated with lower levels of proinflammatory biomarkers in the brain fluid (CSF) of patients with HIV (Watson et al. It is important to note that, once the mode of action of phytocannabinoids and their combination are known, APIs could target specific mechanisms related to inflammation.
Several attempts have been made to inactivate enzymes that degrade cannabinoids, thus increasing the local concentration of endocannabinoids on the surface of tumor cells. Cannabis and its compounds have been shown to have anti-inflammatory activity (see the methodology in Appendix A), but to harness the full potential of cannabis, it is important to define the active molecules and understand the cellular and molecular mechanisms underlying its anti-inflammatory activity. However, the number of studies investigating the health effects of exposure to cannabis smoke remains limited, and it is not well known if there is a relationship between exposure to cannabis smoke and the development of respiratory diseases. Phytocannabinoids are oxygenated aromatic hydrocarbons derived from meroterpenoids with a resorcinyl core structure with isoprenyl, alkyl or aralkyl substitutions.
Leave a Comment